Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer?

Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer?

Submitted by admin on April 26, 2022 - 10:37am
Source: 
Motley Fool
News Tags: 
JNJ
Pfizer
Moderna Therapeutics
vaccines
COVID-19
earnings
pandemic
Headline: 
Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer?
snippet: 
  • The pandemic isn't over, but the vaccine market's growth may be plateauing.
  • Moderna could face crashing revenue in high-income markets.
  • Pfizer will likely fare better than Moderna because its base of revenue is much more diversified.

Do Not Allow Advertisers to Use My Personal information